Aptus Pharma IPO Date, Review, Price, Allotment Details
Aptus Pharma IPO will open on September 23, 2025, and close on September 25, 2025. The IPO is a Book Built Issue, through which the company aims to raise about ₹13.02 crores, entirely as a fresh issue of ₹13.02 crores, along with an offer for sale of up to [.] equity shares with a face value of ₹10 each.
The IPO price band is set at ₹65 to ₹70 per share, with an allocation of 35% for retail investors, 50% for QIBs, and 15% for HNIs. Aptus Pharma is expected to list on the BSE on September 30, 2025, and the IPO allotment will be finalized on September 26, 2025.
On the financial front, the company reported a revenue of ₹24.64 crores in 2025, up from ₹17.88 crores in 2024, and a profit of ₹3.10 crores in 2025, compared to ₹0.80 crores in 2024. Considering these results, investors may look at this IPO for long-term investment potential.
Aptus Pharma IPO Details
IPO Open Date September 23, 2025 IPO Close Date September 25, 2025 Face Value ₹10 Per Equity Share IPO Price Band ₹65 to ₹70 Per Share Issue Size Approx ₹13.02 Crores Fresh Issue Approx ₹13.02 Crores Issue Type Book Built Issue IPO Listing BSE SME DRHP Draft Prospectus 
RHP Draft Prospectus
Aptus Pharma IPO Market Lot
The minimum market lot for Aptus Pharma IPO is 4,000 shares, requiring an application amount of ₹2,80,000.
Application Lot Size Shares Amount Retail Minimum 2 4,000 ₹2,80,000 Retail Maximum 2 4,000 ₹2,80,000 S-HNI Minimum 3 6,000 ₹4,20,000 S-HNI Maximum 7 14,000 ₹9,80,000 B-HNI Minimum 8 16,000 ₹11,20,000
IPO Reservation
Investor Category Share Offered % Shares Market Maker Shares Offered 94,000 Shares 5.05% QIB Shares Offered 8,80,000 Shares 47.31% Anchor Investor 5,28,000 Shares 28.39% QIB (Ex. Anchor) 3,52,000 Shares 18.92% NII Shares Offered 2,66,000 Shares 14.30% bNII > ₹10L – Shares -% sNII < ₹10L – Shares -% Retail Shares Offered 6,20,000 Shares 33.33%
Aptus Pharma IPO Anchor Investors
Anchor Bidding Date September 22, 2025 Anchor Investors List Shares Offered 5,28,000 Shares Anchor Size 3.70 Cr. lock-in period end date 50% shares (30 Days) October 26, 2025 lock-in period end date 50% shares (90 Days) December 25, 2025
Aptus Pharma IPO Dates
The Aptus Pharma IPO will open on September 23, 2025, and close on September 25, 2025. The allotment will be finalized on September 26, with the IPO listing scheduled for September 30, 2025.
IPO Open Date: September 23, 2025 IPO Close Date: September 25, 2025 Basis of Allotment: September 26, 2025 Refunds: September 29, 2025 Credit to Demat Account: September 29, 2025 IPO Listing Date: September 30, 2025 IPO Bidding Cut-off Time: September 25, 2025 – 5 PM
Promoters and Holding Pattern
The promoters of Aptus Pharma are Tejash Maheshchandra Hathi, Chatrabhuj Vallabhbhai Butani, Kapilbhai Hasmukhbhai Chandarana, Ghanshyam Vinubhai Pansuriya, Milly Chetan Lalseta, Riddhish Natwarlal Tanna, Gaurang Rameshchandra Thakker, Kripaliben Mayank Thakker, and Kunjal Piyushbhai Unadkat.
Particular Shares % Share Promoter Holding Pre-Issue 50,00,000 100% Promoter Holding Post Issue 68,60,000 72.89%
Objects of the Issue & Utilisation of Proceeds
Purpose Crores % Capital Expenditure for Office Premises with furniture and Industrial Racks 1.63 -% Working Capital 8.00 -% General Corporate Purpose – -%
About Aptus Pharma IPO
To be updated soon
Aptus Pharma IPO Company Financial Report
The company posted a revenue of ₹24.64 crores in 2025, up from ₹17.88 crores in 2024. Its profit rose to ₹3.10 crores in 2025, compared to ₹0.80 crores in 2024.
Amount ₹ in Crores
Period Ended Revenue Expense PAT Assets 2023 ₹13.90 ₹13.60 ₹0.19 ₹6.22 2024 ₹17.88 ₹16.76 ₹0.80 ₹10.03 2025 ₹24.64 ₹20.44 ₹3.10 ₹21.92
Aptus Pharma IPO Valuation – FY2025
Check Aptus Pharma IPO valuations detail like Earnings Per Share (EPS), Price/Earnings P/E Ratio, Return on Net Worth (RoNW), and Net Asset Value (NAV) details.
KPI Values ROE: 44.50% ROCE: 45.66% EBITDA Margin: 19.31% PAT Margin: -% Debt to equity ratio: 1.49 Earning Per Share (EPS): ₹6.37 (Basic) Price/Earnings P/E Ratio: N/A Return on Net Worth (RoNW): 44.50% Net Asset Value (NAV): ₹13.93
Peer Group Comparison
Company EPS PE Ratio RoNW % NAV Income Zota Health Care Limited 3.16 382.12 2.72 110.83 261.90 Cr. Sunrest Lifescience Limited 4.66 10.56 12.36 37.72 33.12 Cr. Lincoln Pharmaceuticals Limited 41.11 13.53 12.26 335.34 645.71 Cr.
IPO Lead Managers aka Merchant Bankers
- Interactive Financial Services Ltd.
IPO Registrar
Bigshare Services Pvt.Ltd.
Phone: +91-22-6263 8200
Email: ipo@bigshareonline.com
Website: https://ipo.bigshareonline.com/IPO_Status.html
Company Address
Aptus Pharma Ltd.
Ashutosh Buildcon, Opp. Slok – 2,
Nr. Harikrupa Logistic Park,
Aslali, Ahmedabad, Daskroi,
Ahmedabad, Gujarat, 382427
Phone: +91 76004 27827
Email: info@aptuspharma.com
Website: https://aptus-pharma.com/